XML 72 R57.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segments of Business (Tables)
12 Months Ended
Mar. 31, 2018
Segment Reporting [Abstract]  
Schedule of segment information
Financial information relating to our reportable segments and reconciliations to the consolidated totals is as follows:
 
Years Ended March 31,
(In millions)
2018
 
2017
 
2016
Revenues
 
 
 
 
 
Distribution Solutions (1)
 
 
 
 
 
North America pharmaceutical distribution and services
$
174,186

 
$
164,832

 
$
158,469

International pharmaceutical distribution and services
27,320

 
24,847

 
23,497

Medical-Surgical distribution and services
6,611

 
6,244

 
6,033

Total Distribution Solutions
208,117

 
195,923

 
187,999

 
 
 
 
 
 
Technology Solutions - products and services
240

 
2,610

 
2,885

Total Revenues
$
208,357

 
$
198,533

 
$
190,884

 
 
 
 
 
 
Operating profit
 
 
 
 
 
Distribution Solutions (2) (3)
$
1,231

 
$
3,361

 
$
3,553

Technology Solutions (4)
(23
)
 
$
4,215

 
$
519

Total
1,208

 
7,576

 
4,072

Corporate Expenses, Net (5)
(564
)
 
$
(377
)
 
$
(469
)
Loss on Debt Extinguishment
(122
)
 

 
$

Interest Expense
(283
)
 
$
(308
)
 
$
(353
)
Income From Continuing Operations Before Income Taxes
$
239

 
$
6,891

 
$
3,250

 
 
 
 
 
 
Depreciation and amortization (6)
 
 
 
 
 
Distribution Solutions
$
831

 
$
735

 
$
669

Technology Solutions
9

 
65

 
107

Corporate
111

 
110

 
109

Total
$
951

 
$
910

 
$
885

 
 
 
 
 
 
Expenditures for long-lived assets (7)
 
 
 
 
 
Distribution Solutions
$
306

 
$
276

 
$
306

Technology Solutions

 
30

 
15

Corporate
99

 
98

 
167

Total
$
405

 
$
404

 
$
488

 
 
 
 
 
 
Revenues, net by geographic area (8)
 
 
 
 
 
United States
$
169,943

 
$
164,428

 
$
158,255

Foreign
38,414

 
34,105

 
32,629

Total
$
208,357

 
$
198,533

 
$
190,884


(1)
Revenues derived from services represent less than 2% of this segment’s total revenues.
(2)
Distribution Solutions segment’s operating profit for 2018 includes non-cash pre-tax goodwill impairment charges of $1,283 million for our McKesson Europe reporting unit and $455 million for our Rexall Health reporting unit. This segment’s operating profit for 2018 also includes non-cash pre-tax asset impairment charges of $446 million and pre-tax restructuring charges of $74 million for our McKesson Europe business. Operating profit for 2017 and 2016 includes $144 million and $76 million of net cash proceeds representing our share of net settlements of antitrust class action lawsuits, and for 2016 also includes a pre-tax gain of $52 million recognized from the sale of our ZEE Medical business.
(3)
Distribution Solutions segment’s operating profit for 2018 and 2017 includes pre-tax credits of $99 million and $7 million and for 2016 a pre-tax charge of $244 million related to our LIFO method of accounting for inventories. LIFO credits were higher in 2018 compared to 2017 due to higher net effect of price declines, partially offset by lower inventory level. LIFO expense was recognized in 2016 primarily due to net effects of price increases.
(4)
Technology Solutions segment’s operating profit for 2018 includes a pre-tax gain of $109 million from the 2018 third quarter sale of our EIS business. Operating profit for 2017 includes a pre-tax gain of $3,947 million recognized from the Healthcare Technology Net Asset Exchange, net of transaction and related expenses and a non-cash pre-tax charge of $290 million for goodwill impairment related to the EIS reporting unit. Operating profit for 2016 includes a pre-tax gain of $51 million recognized from the sale of our nurse triage business.
(5)
In 2016, the Company implemented the Cost Alignment Plan to reduce its operating expenses and recorded pre-tax restructuring charges of $229 million. Pre-tax charges for 2016 were recorded as follows: $161 million, $51 million and $17 million within our Distribution Solutions segment, Technology Solutions segment and Corporate.
(6)
Amounts primarily include amortization of acquired intangible assets purchased in connection with business acquisitions, capitalized software held for sale and capitalized software for internal use.
(7)
Long-lived assets consist of property, plant and equipment.
(8)
Net revenues were attributed to geographic areas based on the customers’ shipment locations.
Schedule of segment assets and property, plant and equipment, net by geographic areas
Segment assets and property, plant and equipment, net by geographic areas were as follows:
 
March 31,
(In millions)
2018
 
2017
Segment assets
 
 
 
Distribution Solutions
$
53,915

 
$
52,322

Technology Solutions
3,735

 
4,995

Corporate
2,731

 
3,652

Total
$
60,381

 
$
60,969

 
 
 
 
Property, plant and equipment, net


 


United States
$
1,529

 
$
1,383

Foreign
935

 
909

Total
$
2,464

 
$
2,292